PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-Day postinfection period
about
Diagnosis of lyme borreliosis.Chronic Lyme disease: a reviewAntibiotic treatment of animals infected with Borrelia burgdorferiUpdate on Canine and Feline Blood Donor Screening for Blood-Borne PathogensLyme and associated tick-borne diseases: global challenges in the context of a public health threatReviewing molecular adaptations of Lyme borreliosis spirochetes in the context of reproductive fitness in natural transmission cyclesLeishmania tropica in rock hyraxes (Procavia capensis) in a focus of human cutaneous leishmaniasisHumoral immune response in dogs naturally infected with Borrelia burgdorferi sensu lato and in dogs after immunization with a Borrelia vaccineUse of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors.Comparison of phenology and pathogen prevalence, including infection with the Ehrlichia muris-like (EML) agent, of Ixodes scapularis removed from soldiers in the midwestern and the northeastern United States over a 15 year period (1997-2012).Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR.Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A.Lyme disease: the next decade.Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome.Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi.Real-time PCR for simultaneous detection and quantification of Borrelia burgdorferi in field-collected Ixodes scapularis ticks from the Northeastern United StatesEvaluation of the preventive capacities of a topically applied azithromycin formulation against Lyme borreliosis in a murine modelVaccination with the ospA- and ospB-Negative Borrelia burgdorferi Strain 50772 Provides Significant Protection against Canine Lyme DiseasePersistence of Borrelia burgdorferi following antibiotic treatment in miceDetection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viabilityBacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.Cooperation of Doxycycline with Phytochemicals and Micronutrients Against Active and Persistent Forms of Borrelia spChronic brucellosis and persistence of Brucella melitensis DNA.Borrelia burgdorferi sensu lato species in Europe induce diverse immune responses against C6 peptides in infected mice.Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study.Repeat or persistent Lyme disease: persistence, recrudescence or reinfection with Borrelia Burgdorferi?Quantitative measurement of C6 antibody following antibiotic treatment of Borrelia burgdorferi antibody-positive nonclinical dogs.Borrelia burgdorferi organisms lacking plasmids 25 and 28-1 are internalized by human blood phagocytes at a rate identical to that of the wild-type strain.Persistent Borrelia Infection in Patients with Ongoing Symptoms of Lyme Disease.
P2860
Q22242237-CCE0B5F8-0320-414E-B88D-7206EFE429ECQ22252200-19B4CB25-0DC1-4944-87BD-F7CAC0D4647DQ24650857-2E3630FD-FCF6-4800-821B-0692391BB969Q26775073-E35F2A28-94F9-4513-9C4F-A79AA9C987F9Q26829842-9C9B4D1C-21BD-4C99-9EE9-DE8BC06BBB4EQ27488839-64189F31-EEA7-4A17-BD76-CC4B150CAA1DQ33817551-CA773C6A-9741-4AD6-B361-2D2E2D6DB6D9Q33825716-ED019F0E-1D5C-442A-A0CE-DBA9EE9E2028Q33974101-9504AD98-C4F0-437E-9C09-A5CD0F2BF96AQ34694166-6C9662EC-6B69-4FA0-BE8E-FFD4DBC5297DQ34734039-C79B492E-B05E-4D1F-A4F3-9C5870896894Q34943232-942F5E75-64CA-4381-84AA-8AF4B1E5584AQ35026635-DFF5F8B8-7E5B-4354-9B47-4DC4F2EB1827Q35066111-AF276C4E-ACDA-4A44-8EB4-C685E5A98246Q35095320-E8A59036-5FC6-40FE-9E02-299319C072BBQ35209267-AC98F6CE-97AA-4AD9-8D06-143EC1278632Q35547622-A9E9A3A3-85F4-4B3C-8C46-EF02BD2810A9Q35773884-57762567-B4F0-4AD0-8431-E0CC93EB388EQ36593814-FD5DFDFD-DD8E-419C-B108-8C46EC4FC23EQ36667562-D02C5373-787B-45D7-AFC0-0761A28B1B0EQ37099227-2E2CD006-6EF5-4089-96E1-F94483FA402AQ37201989-624F0D0B-4459-4423-8570-C5FE6A037679Q37256353-329D7BCD-2696-4476-9551-A91077C59A12Q37410021-571C2DC0-3338-4258-A5E9-7A9BFF918CB5Q37635036-15ABE674-0501-42A2-BBB6-5EBE15731A27Q38364205-33446679-09B6-4D97-97B2-6F0AA2642ED3Q41912119-B08AC536-1A2E-4809-B517-A387EC4F06D8Q43013530-A94125C2-A12F-4C2C-AA71-110F85FA20B5Q54091973-C02B5BAD-F806-44BF-B39D-E1359C260A3F
P2860
PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-Day postinfection period
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
PCR-Based quantification of Bo ...... a 500-Day postinfection period
@ast
PCR-Based quantification of Bo ...... a 500-Day postinfection period
@en
type
label
PCR-Based quantification of Bo ...... a 500-Day postinfection period
@ast
PCR-Based quantification of Bo ...... a 500-Day postinfection period
@en
prefLabel
PCR-Based quantification of Bo ...... a 500-Day postinfection period
@ast
PCR-Based quantification of Bo ...... a 500-Day postinfection period
@en
P2860
P1476
PCR-Based quantification of Bo ...... a 500-Day postinfection period
@en
P2093
R K Straubinger
P2860
P304
P407
P577
2000-06-01T00:00:00Z